smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
smartbax's investors include HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund, Bayern Kapital, UnternehmerTUM, Anobis Asset.
smartbax is headquartered in Munich, Germany.
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
smartbax is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"smartbax — Funding & Investors." VCBacked, June 30, 2026, https://www.vcbacked.co/company/smartbax. Accessed July 30, 2026.
VCBacked. (2026). smartbax — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/smartbax
{{cite web |title=smartbax — Funding & Investors |url=https://www.vcbacked.co/company/smartbax |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated